Profile of use of off-label and non-licensed drugs in a neonatal Intensive Care Unit
DOI:
https://doi.org/10.33448/rsd-v13i7.45643Keywords:
Newborn; Off-label use; Intensive Care Units, neonatal.Abstract
Objective: The off-label drug prescription is unavoidable in neonatal and pediatric clinical practice and its use may result risks. This study was conducted to characterize the epidemiological profile of off-label and/or unlicensed drugs prescribed to patients in a neonatal intensive care unit of a high-complexity exclusively pediatric hospital in Brazil. Methods: descriptive and cross-sectional study, including all medical prescriptions for the year 2019. Data were expressed as mean and median, or absolute and relative frequency. Results: 24,787 prescription items were recorded for 102 medications. Of these, 58% were off-label and 25% unlicensed. The most prescribed drug classes were anti-infective and central nervous system drugs. Moreover, 12% were classified as high-surveillance drugs, principally fentanyl (51.0%) as the main drug. Conclusion: this study reinforces the importance of the pharmacist as a fundamental strategy in understanding the epidemiological profile of drugs used in neonatology and the potential adverse reactions that these drugs can cause.
References
Allegaert, K., & van den Anker, J. N. (2014). Clinical pharmacology in neonates: small size, huge variability. Neonatology, 105(4), 344-349. https://doi.org/10.1159/000360648
Ancora, G., Lago, P., Garetti, E., Merazzi, D., Savant Levet, P., Bellieni, C. V., Pieragostini, L., & Pirelli, A. (2019). Evidence-based clinical guidelines on analgesia and sedation in newborn infants undergoing assisted ventilation and endotracheal intubation. Acta Paediatr, 108(2), 208-217. https://doi.org/10.1111/apa.14606
ANVISA. (2005). Como a Anvisa vê o uso off-label de medicamentos. Brasília. Disponível em: <http://www.anvisa.gov.br/medicamentos/registro/registro_offlabel.htm> Acesso em: 18/05/20.
Arnold, B. C. Pareto Distribution. In Wiley StatsRef: Statistics Reference Online (pp. 1-10). https://doi.org/https://doi.org/10.1002/9781118445112.stat01100.pub2
Bellù R, R. O., Nava C, de Waal KA, Zanini R, Bruschettini M. (2021). Opioids for newborn infants receiving mechanical ventilation. Cochrane Database of Systematic Reviews, Issue 3. https://doi.org/10.1002/14651858.CD013732.pub2.
Blanco-Reina, E., Medina-Claros, A. F., Vega-Jiménez, M. A., Ocaña-Riola, R., Márquez-Romero, E. I., & Ruiz-Extremera, Á. (2016). Utilización de fármacos en niños en cuidados intensivos: estudio de las prescripciones off-label. Medicina Intensiva, 40(1), 1-8. https://doi.org/https://doi.org/10.1016/j.medin.2014.11.007
Carvalho, C. G., Ribeiro, M. R., Bonilha, M. M., Fernandes Jr, M., Procianoy, R. S., & Silveira, R. C. J. J. d. P. (2012). Uso de medicamentos off-label e não licenciados em unidade de tratamento intensivo neonatal e sua associação com escores de gravidade. 88(6), 465-470.
Costa, P. Q. d., Rey, L. C., & Coelho, H. L. L. (2009). Carência de preparações medicamentosas para uso em crianças no Brasil %J Jornal de Pediatria. 85, 229-235. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572009000300008&nrm=iso
Dos Santos, L., & Heineck, I. (2012). Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications. Farm Hosp, 36(4), 180-186. https://doi.org/10.1016/j.farma.2010.12.008
Engle, K. K., & Hannawa, T. E. (1999). Techniques for administering oral medications to critical care patients receiving continuous enteral nutrition. American Journal of Health-System Pharmacy, 56(14), 1441-1444. https://doi.org/10.1093/ajhp/56.14.1441 %J American Journal of Health-System Pharmacy
Estrela, C. (2018). Metodologia científica: ciência, ensino, pesquisa. Artes médicas.
Ferreira, L. d. A., Ibiapina, C. d. C., Machado, M. G. P., & Fagundes, E. D. T. J. R. d. A. M. B. (2012). A alta prevalência de prescrições de medicamentos off-label e não licenciados em unidade de terapia intensiva pediátrica brasileira. 58(1), 82-87.
Gil, A. C. (2002). Como elaborar projetos de pesquisa. Editora Atlas SA.
Girardi, A., Galletti, S., Raschi, E., Koci, A., Poluzzi, E., Faldella, G., & De Ponti, F. (2017). Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit. Ital J Pediatr, 43(1), 37. https://doi.org/10.1186/s13052-017-0354-z
Gore, R., Chugh, P. K., Tripathi, C. D., Lhamo, Y., & Gautam, S. (2017). Pediatric Off-Label and Unlicensed Drug Use and Its Implications. Curr Clin Pharmacol, 12(1), 18-25. https://doi.org/10.2174/1574884712666170317161935
Hsieh, E. M., Hornik, C. P., Clark, R. H., Laughon, M. M., Benjamin, D. K., Jr., Smith, P. B., & Best Pharmaceuticals for Children Act—Pediatric Trials, N. (2014). Medication use in the neonatal intensive care unit. American journal of perinatology, 31(9), 811-821. https://doi.org/10.1055/s-0033-1361933
Işık, M., Kaya, Z., Belen, F. B., Aktaş, A. T., Tezer, H., & Gürsel, T. (2014). Life-threatening agranulocytosis, anemia, and plasmacytosis after dipyrone use for fever in a child. J Pediatr Hematol Oncol, 36(1), e46-48. https://doi.org/10.1097/MPH.0b013e31826e7d9d
Kalikstad, B., Skjerdal, Å., & Hansen, T. W. R. J. A. o. d. i. c. (2010). Compatibility of drug infusions in the NICU. 95(9), 745-748.
Laforgia, N., Nuccio, M. M., Schettini, F., Dell'Aera, M., Gasbarro, A. R., Dell'Erba, A., & Solarino, B. (2014). Off-label and unlicensed drug use among neonatal intensive care units in Southern Italy. Pediatr Int, 56(1), 57-59. https://doi.org/10.1111/ped.12190
Mason, J., Pirmohamed, M., & Nunn, T. J. E. j. o. c. p. (2012). Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literature. 68(1), 21-28.
Merchán-Hamann, E., & Tauil, P. L. (2021). Proposal for classifying the different types of descriptive epidemiological studies. Epidemiologia e Serviços de Saúde, 30, e2018126.
Micromedex®. (2006). Micromedex® Healthcare Series [Internet database]. In: Thomson Reuters (Healthcare) Greenwood Village (CO).
Moore, H. L. (1897). Cours d'Économie Politique. By Vilfredo Pareto, Professeur à l'Université de Lausanne. Vol. I. Pp. 430. I896. Vol. II. Pp. 426. I897. Lausanne: F. Rouge. The ANNALS of the American Academy of Political and Social Science, 9(3), 128-131. https://doi.org/10.1177/000271629700900314
Nunes, P. H. C., Pereira, B. M. G., Nominato, J. C. S., Albuquerque, E. M. d., Silva, L. d. F. N. d., Castro, I. R. S. d., & Castilho, S. R. d. J. R. B. d. C. F. (2008). Intervenção farmacêutica e prevenção de eventos adversos. 44(4), 691-699.
O’Brien, F., Clapham, D., Krysiak, K., Batchelor, H., Field, P., Caivano, G., Pertile, M., Nunn, A., & Tuleu, C. (2019). Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine. 20(11), 2688. https://www.mdpi.com/1422-0067/20/11/2688
Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica.
Pinheiro, L., Brito, C. I., Pereira, V. C., Oliveira, A., Camargo, C. H., & Cunha Mde, L. (2014). Reduced susceptibility to vancomycin and biofilm formation in methicillin-resistant Staphylococcus epidermidis isolated from blood cultures. Mem Inst Oswaldo Cruz, 109(7), 871-878. https://doi.org/10.1590/0074-0276140120
Rostas, S. (2018). Ethical Considerations of a Neonatal Intensive Care Unit Pharmacist. The Journal of Perinatal & Neonatal Nursing, 32, 21-23. https://doi.org/10.1097/JPN.0000000000000311
Srinivasan, A., Dick, J. D., & Perl, T. M. (2002). Vancomycin resistance in staphylococci. Clinical microbiology reviews, 15(3), 430-438. https://doi.org/10.1128/cmr.15.3.430-438.2002
Stewart, D., Rouf, A., Snaith, A., Elliott, K., Helms, P. J., & McLay, J. S. (2007). Attitudes and experiences of community pharmacists towards paediatric off-label prescribing: a prospective survey. Br J Clin Pharmacol, 64(1), 90-95. https://doi.org/10.1111/j.1365-2125.2007.02865.x
Taketomo, C. K., Hodding, J. H., & Kraus, D. (2010). Pediatric and neonatal dosage handbook. Hudson (OH): Lexi Comp.
Toassi, R. F. C., & Petry, P. C. (2021). Metodologia científica aplicada à área da Saúde.
WHO. (2021). VigiAccess. http://www.vigiaccess.org/
Yue, Y., Chen, L., Choonara, I., Xiong, T., Ojha, S., Tang, J., Wang, Y., Zeng, L., Shi, J., Wang, H., & Mu, D. (2020). Cross-sectional study of drug utilisation in a Chinese neonatal unit. The Journal of international medical research, 48(5), 300060520914197-300060520914197. https://doi.org/10.1177/0300060520914197
Zheng, Z., Zeng, Y., & Huang, H. (2018). Pharmacists’ role in off-label drug use in China. 25(2), 116-116. https://doi.org/10.1136/ejhpharm-2017-001283 %J European Journal of Hospital Pharmacy
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Fernanda Toaldo; Rafaela Raeski Hauagge; Heloísa Arruda Gomm Barreto; Juliane Kuster Bauer; Mariana Millan Fachi; Marinei Campos Ricieri
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
